Target
MAP kinase-interacting serine/threonine-protein kinase 2
Ligand
BDBM105193
Substrate
n/a
Meas. Tech.
ChEMBL_1879553 (CHEMBL4380947)
IC50
3700±n/a nM
Citation
 Kwiatkowski, JLiu, BPang, SAhmad, NHBWang, GPoulsen, AYang, HPoh, YRTee, DHYOng, ERetna, PDinie, NKwek, PWee, JLKManoharan, VLow, CBSeah, PGPendharkar, VSangthongpitag, KJoy, JBaburajendran, NJansson, AENacro, KHill, JKeller, THHung, AW Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2. J Med Chem 63:621-637 (2020) [PubMed]  Article
Target
Name:
MAP kinase-interacting serine/threonine-protein kinase 2
Synonyms:
GPRK7 | MAP kinase signal-integrating kinase 2 | MAP kinase-interacting serine/threonine-protein kinase 2 (MKNK2) | MAP kinase-interacting serine/threonine-protein kinase 2 (MnK2) | MAP-kinase interacting kinase 2 (MNK2) | MKNK2 | MKNK2_HUMAN | MNK2
Type:
Protein
Mol. Mass.:
51870.79
Organism:
Homo sapiens (Human)
Description:
Q9HBH9
Residue:
465
Sequence:
MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA
  
Inhibitor
Name:
BDBM105193
Synonyms:
4‐(1H‐imidazol‐1‐yl)phenol (Compound 1) | 4-(1H-imidazol-1-yl)phenol
Type:
Small organic molecule
Emp. Form.:
C9H8N2O
Mol. Mass.:
160.1726
SMILES:
Oc1ccc(cc1)-n1ccnc1
Structure:
Search PDB for entries with ligand similarity: